Hologic Nabs FDA 510(k) Clearance for Respiratory Assay
The multiplex real-time RT-PCR test for SARS-CoV-2, influenza A and B, and RSV is designed for use on the firm's high-throughput Panther Fusion instrument.
SD Biosensor Eyes Global Expansion as Evaluations Find Rapid MDx System on Par With Competition
The sample-to-answer system can multiplex up to 12 targets and can run both isothermal assays and RT-PCR with results in 30 minutes or 60 minutes, respectively.
BGI Genomics Gets Australian Regulatory Approval for Multiplexed SARS-CoV-2, Influenza Test
The RT-PCR-based test is designed to simultaneously detect and differentiate SARS-CoV-2, influenza A, and influenza B from throat swab samples.
LexaGene Files for Chapter 7 Bankruptcy
The company has ceased operations and laid off staff, while a bankruptcy trustee will liquidate its assets and distribute any proceeds.
Becton Dickinson Nabs FDA EUA for COVID-19, Influenza, RSV Test
The assay runs on the BD Max Molecular Diagnostic System and returns results in as little as two hours from a nasal or nasopharyngeal swab.